Disc Medicine (IRON) Short term Debt (2020 - 2022)

Disc Medicine (IRON) has reported Short term Debt for 3 consecutive years, with $2.9 million the latest figure, recorded in Q2 2022.

• In Q2 2022, Short term Debt fell 41.74% year-over-year to $2.9 million; the TTM figure through Jun 2022 stood at $2.9 million (down 41.74% YoY), while the FY2021 annual figure was $5.0 million, changed 0.0% from the prior year.
• Short term Debt declined to $2.9 million in Q2 2022 per IRON's latest filing, from $4.2 million in the prior quarter.
• Across five years, Short term Debt topped out at $5.0 million in Q4 2020 and bottomed at $2.9 million in Q2 2022.
• Historically, Short term Debt has averaged $4.6 million across 3 years, with a median of $5.0 million in 2020.
• Annual changes were most pronounced in 2021 — Short term Debt changed 0.0% — and 2022, when it slumped 41.74%.
• Disc Medicine's Short term Debt stood at $5.0 million in 2020, then changed by 0.0% to $5.0 million in 2021, then plunged by 41.74% to $2.9 million in 2022.
• Business Quant data shows IRON's Short term Debt at $2.9 million in Q2 2022, $4.2 million in Q1 2022, and $5.0 million in Q4 2021.